Clinical Trials in San Antonio

Showing 7381-7400 of 11,125 trials

A Study of LY2584702 in Participants With Advanced Cancer

NCT01394003

The main purpose of this trial is to determine a recommended Phase 2 dose of LY2584702 that may be safely administered to participants with advanced/metastatic cancer.

Advanced Cancer

Eli Lilly and Company34 participantsStarted Nov 2008

Santa Monica, California, United States • San Antonio, Texas, United States

COMPLETEDPhase 3< 1 mile

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

NCT01372150

This is a Double-blind Study Evaluating Desvenlafaxine Succinate (DVS SR) Sustained Release vs Placebo in the Treatment of Children and Adolescent Outpatients with Major Depressive Disorder (MDD).

Major Depressive Disorder

Pfizer340 participantsStarted Nov 2011

Dothan, Alabama, United States • Goodyear, Arizona, United States • Tucson, Arizona, United States +40 more locations

A Study of LY2584702 in Participants With Advanced Cancer

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Find Trials by Condition in San Antonio

A Study of Safety and Efficacy of BTD-001 in Treatment of Patients With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2

A Study to Assess the Efficacy and Safety of AXS-02 in Subjects With Knee OA Associated With Bone Marrow Lesions

Evaluating the Safety and Efficacy of LIPO-202 for the Reduction of Central Abdominal Bulging Due to Subcutaneous Fat (AbCONTOUR2)

Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery Disease

Early Access Treatment With Daratumumab for (Relapsed or Refractory) Multiple Myeloma

Study of LY573636-sodium in Essential Thrombocythemia and Acute Myeloid Leukemia

A Randomized, Double-blind, Study to Explore the Effect of GED-0301 in Subjects With Active Crohn's Disease

A Study of Vadastuximab Talirine Given Prior to or After Allogeneic Hematopoietic Stem Cell Transplant in AML Patients

JKB-121 for the Treatment of Nonalcoholic Steatohepatitis

Study Of Dacomitinib (PF-00299804) In Advanced NSCLC Patients (Post Chemo Or Select First Line) To Evaluate Prophylactic Intervention On Derm And GI AEs And PRO

Study Evaluating Prophylaxis Treatment & Characterizing Efficacy, Safety, & PK Of B-Domain Deleted Recombinant FVIII

Omadacycline vs Moxifloxacin for the Treatment of CABP (EudraCT #2013-004071-13)

Topotecan in Treating Women With Persistent or Recurrent Cervical Cancer

Dacomitinib (PF-00299804) As A Single Oral Agent In Selected Patients With Adenocarcinoma Of The Lung

Detection of Cytomegalovirus Virus in Neonates

A Study of Atezolizumab in Participants With Programmed Death-Ligand 1 (PD-L1) Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) [FIR]

Axitinib For The Treatment Of Advanced Hepatocellular Carcinoma

PRospective Study to Evaluate EffectivenesS With the NURO™ PErcutaneous Tibial Neuromodulation System in Patients With OAB